DiscoverNETCastNET Doctors Discuss Highlights from ASCO2024
NET Doctors Discuss Highlights from ASCO2024

NET Doctors Discuss Highlights from ASCO2024

Update: 2024-02-16
Share

Description

Dr. Simron Singh is a medical oncologist, affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute, and an assistant professor at the University of Toronto. Dr. Singh is a longtime member of NANETS and the current Treasurer of its Board of Directors.

Dr. Alexandria T. Phan is a Professor of Internal Medicine and Medical Oncology at Froedtert & Medical College of Wisconsin, with a special focus on neuroendocrine tumors and malignancies of the GI tract. Dr. Phan is a member of NANETS' Communications and the moderator of this discussion. The doctors will discuss highlights from the recent ASCO meeting, with a special focus on the results of the phase 3 randomized NETTER-2 study. This is the first randomized study to demonstrate efficacy of RLT as 1L treatment in any malignancy and will change clinical practice.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NET Doctors Discuss Highlights from ASCO2024

NET Doctors Discuss Highlights from ASCO2024